Features of pregnancy and delivery in patients with pregnancy-induced hypertension
- Authors: Khasan S.M.1
-
Affiliations:
- Ogarev Mordovia State University, Medical Institute, Saransk, Russia
- Issue: Vol 96, No 4 (2015)
- Pages: 558-563
- Section: Reviews
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/2249
- DOI: https://doi.org/10.17750/KMJ2015-558
- ID: 2249
Cite item
Full Text
Abstract
Pregnant women with hypertensive disorders have a high risk for premature birth and early delivery due to the increased severity of hypertension associated with low effect of treatment. Vaginal birth in patients with hypertensive disorders are often complicated by premature rupture of membranes, labor abnormalities, abnormal blood loss. Emergency abdominal delivery is performed together with complex intensive therapy. A common approach to the management of pregnancies with mild and moderate forms of hypertension is treatment associated with prolongation of pregnancy. Therapeutic and protective regimen in childbirth is created by phased long-term epidural analgesia. Indications for induced delivery - I-II degree of nephropathy in the absence of a positive therapeutic effect for 1-2 weeks. Regarding to severe forms of hypertensive disorders, many researchers tend to think of the need for early delivery, to avoid complications. At the same time, early delivery often leads to birth with premature fetus, which contributes to worsening of perinatal outcomes in patients with hypertensive disorders. Currently the possibility of conservative management of pregnant with hypertensive disorders at the gestation term of less than 32 weeks using glucocorticoids may significantly improve perinatal outcomes. Conservative management is only possible in large clinical settings with careful selection of patients. Currently, there are different approaches to the selection of methods and timing of delivery in hypertensive disorders. The optimal strategy is based on a differentiated approach that takes into account the severity of hypertensive disorders and the probability of complications for mother and fetus. At the same time, the diversity of the pathogenesis of hypertensive disorders determines the presence of different variants of its clinical manifestations, clinical course and complications, making it difficult to properly assess its severity.
About the authors
SKh Mansur Khasan
Ogarev Mordovia State University, Medical Institute, Saransk, Russia
Author for correspondence.
Email: inst-med@adm.mrsu.ru
References
- Абрамченко В.В., Шахмалова И.А., Ланцев Е.А. Кесарево сечение в перинатальной медицине. - СПб.: ЭЛБИ СПб., 2005. - 226 с.
- ВОЗ. Материнская смертность. Информационный бюллетень №348. Май 2014 г. - http://www.who.int/mediacentre/factsheets/fs348/ru/ (дата обращения: 18.06.15)
- Диагностика, профилактика и лечение гестозов: методические рекомендации / Под ред. О.Н. Харкевича, И.И. Кануса, А.Н. Буяновой, Ю.К. Малевича. - Минск, 2001. - 32 с.
- Киселёва Н.И. Особенности течения беременности и родов при гестозе // Охрана материнства и детства. - 2006. - №2-8. - С. 8-13.
- Краснопольский В.И., Логутова Л.C., Мазурская Н.М. и др. Принципы интенсивной терапии беременных с гестозом при подготовке к родоразрешению // Рос. вестн. акуш. гин. - 2004. - Т. 4, №2. - С. 65-69.
- Макаров O.B., Ткачёва О.Н., Волкова Е.В. Преэклампсия и хроническая артериальная гипертензия. Клинические аспекты. - М.: ГЭОТАР-Медиа, 2010. - 178 с.
- Марусов А.П. Сочетанные формы позднего гестоза беременных. - Саранск: изд-во Мордов. ун-та, 2005. - 180 с.
- Мурашко Л.E. Гестозы. Актуальные вопросы патологии родов, плода и новорождённого. Пособие для врачей. - М.: Медицина, 2000. - 234 с.
- Савельева Г.М., Шалина Р.И., Курцер М.А. и др. Эклампсия в современном акушерстве // Акушер. и гинекол. - 2010. - №6. - С. 4-9.
- Стародубов В.И., Суханова Л.П. Репродуктивные проблемы демографического развития России. - М.: Менеджер здравоохранения, 2012. - 320 с.
- Стрюк Р.И., Брыткова Я.В., Бухонкина Ю.М., Павлова Л.Н. Клиническая эффективность антигипертензивной терапии пролонгированным нифедипином и бисопрололом беременных с артериальной гипертонией // Кардиология. - 2008. - Т. 48, №4. - С. 29-33.
- Сухих Г.Т., Ткачёва О.Н., Ляшко Е.С. и др. Диагностика и лечение артериальной гипертонии у беременных. - М.: Миклош, 2011. - 343 с.
- Шалина Р.И. Гестозы. Современное состояние вопроса // Акушер. и гинекол. - 2007. - №5. - С. 27-33.
- Andersgaard A.B., Acharya G., Mathiesen E.B. et al. Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study // Am. J. Obstet. Gynecol. - 2012. - Vol. 206. - N 2. - P. 1-8. http://dx.doi.org/10.1016/j.ajog.2011.09.032
- Barton J.R., Barton L.A., Istwan N.B. et al. Elective delivery at 340/7 to 366/7 weeks’ gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension // Am. J. Obstet. Gynecol. - 2011. - Vol. 204, N 44. - Р. e1-e5. http://dx.doi.org/10.1016/j.ajog.2010.08.030
- Barton J.R., Sibai B.M. Prediction and prevention of recurrent preeclampsia // Obstet. Gynecol. - 2008. - Vol. 112, N 2, рt. 1. - P. 359-372. http://dx.doi.org/10.1097/AOG.0b013e3181801d56
- Chappal L.C., Enye St., Seed P. et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study // Hypertension. - 2008. - Vol. 51. - P. 1002-1009. http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.107565
- Ghulmiyyah L., Sibai В. Maternal mortality from preeclampsia/eclampsia // Semin. Perinatol. - 2012. - Vol. 36, N 1. - Vol. 56-59. http://dx.doi.org/10.1053/j.semperi.2011.09.011
- Giguere Y., Charland M., Bujold E. et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review // Clin. Chemistry. - 2010. - Vol. 56 , N 3. - P. 361-375. http://dx.doi.org/10.1373/clinchem.2009.134080
- Hofmeyr G.J., Lawrie Т.А., Atallah B.N., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems // Cochr. Dat. Syst. Rev. - 2010. - Vol. 8. - CD001059. http://dx.doi.org/10.1002/14651858.CD001059.pub3
- Kanasaki K., Kalluri R. The biology of preeclampsia // Kidney Intern. - 2009. - Vol. 76, N 8. - P. 831-837. http://dx.doi.org/10.1038/ki.2009.284
- Karumanchi S.A., Lindheimer M.D. Advances in Understanding of eclampsia // Curr. Hypertens. Rep. - 2008. - Vol. 10. - P. 305-312.
- Leanos-Miranda A., Campos-Galicia I., Isordia-Salas I. et al. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia // J. Hypertens. - 2012. - Vol. 30, N 11. - P. 2173-2181. http://dx.doi.org/10.1097/HJH.0b013e328357c0c9
- Magee L.A., Helewa M., Moutquin J.M., von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Journal of obstetrics and gynaecology Canada // JOGC. - 2008. - Vol. 30, N 3. - Р. 1-48.
- Meler E., Figueras F., Bennasar M. et al. The prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia // Am. J. Obstet. Gynecol. - 2010. - Vol. 202, N 6. - P. 551-554. http://dx.doi.org/10.1016/j.ajog.2010.01.048
- RCOG. Guideline No. 10 (A). The Management of Severe Pre-eclampsia/Eclampsia 2010. - http://lib.nsmu.ru/student/faculty/department/obstetrics/for students/RCOG The Management of Severe Preeclampsia.pdf (дата обращения: 01.04.15).
- Roberge S., Giguere Y., Villa P. et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta- analysis // Am. J. Perinatol. - 2012. - Vol. 29, N 7. - P. 551-556. http://dx.doi.org/10.1055/s-0032-1310527
- Steegers E.A., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia // Lancet. - 2010. - Vol. 21, N 376 (9741). - Р. 631-442. http://dx.doi.org/10.1016/S0140-6736(10)60279-6
- Towner D., Gandhi S., El Kady D. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin // Am. J. Obstet. Gynecol. - 2006. - Vol. 194, N 6. - P. 1676-1681. http://dx.doi.org/10.1016/j.ajog.2006.03.011
- Valenzuela F., Perez-Sepulveda A., Torres M.J. et al. Pathogenesis of preeclampsia: the genetic component. Review article // J. Pregn. - 2012. - Article ID 632732, 8 pages. http://dx.doi.org/10.1155/2012/632732